Literature DB >> 336199

Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.

T Buroker, A Miller, L Baker, M McKenzie, M Samson, V K Vaitkevicius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 336199

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.

Authors:  B Schultze; W Jellinghaus; G Weis; V Müller; W Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

2.  Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.

Authors:  Tetsuhiko Shirasaka
Journal:  Jpn J Clin Oncol       Date:  2008-12-03       Impact factor: 3.019

3.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.